Albumin News and Research

RSS

New method produces hydrogels that have properties similar to cells’ environment

Scientists at Linköping University have developed a new method to produce hydrated materials, hydrogels, that have properties similar to the natural environment of cells in the body.

13 Feb 2019

Iridium attached to albumin can attack cancer cells when blasted with light

A new compound based on Iridium, a rare metal which landed in the Gulf of Mexico 66 M years ago, hooked onto albumin, a protein in blood, can attack the nucleus of cancerous cells when switched on by light, University of Warwick researchers have found.

4 Feb 2019

Excessive suppression of GSK3 enzyme can trigger renal failure, finds study

Scientists have identified an enzyme that is a "master regulator" of kidney function that if excessively suppressed, can trigger renal failure. Their findings have implications for the use of existing drugs and the development of new pharmaceuticals.

24 Jan 2019

FDA approves new treatment for rare disease of the bone marrow and blood

The U.S. Food and Drug Administration today approved Elzonris (tagraxofusp-erzs) infusion for the treatment of blastic plasmacytoid dendritic cell neoplasm in adults and in pediatric patients, two years of age and older.

21 Dec 2018

Study provides information about chemotherapeutic drugs binding to plasma proteins

Chemotherapy is use of drugs to cure a disease but more specifically, it refers to drug therapy for cancer. Cancer chemotherapy can be done with a single drug or a combination of drugs and is usually systematic in nature, that is to say that a drug is administered through the blood circulation to eliminate cancer cells in many parts of the body.

21 Dec 2018

Treating patients with hypertension induced albuminuria

Albuminuria is a renal disease that is found to be independently associated with cardiovascular and renal problems without any links to diabetes. In latest ESC/ESH guidelines, microalbuminuria has been related to hypertension-mediated organ damages.

10 Dec 2018

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech, a member of the Roche Group, today announced positive results from the Phase III IMpower130 study of Tecentriq (atezolizumab) plus chemotherapy (carboplatin and Abraxane® [albumin-bound paclitaxel; nab-paclitaxel]) for the initial (first-line) treatment of people with previously untreated metastatic non-squamous non-small cell lung cancer.

22 Oct 2018

Study investigates effects of glucose-lowering drug in preventing damage to the kidneys

New research presented at the annual meeting of the European Association for the Study of Diabetes and published simultaneously in The Lancet Diabetes & Endocrinology shows how the glucose-lowering drug lixisenatide can slow or prevent damage to the kidneys in macro-albuminuric patients with type 2 diabetes mellitus and cardiovascular disease.

3 Oct 2018

Common biomarker of kidney disease may also indicate COPD

A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

28 Sep 2018

Study aims to investigate risk factors for PPCs in surgical patients with gastric cancer

As one of the most common malignant tumors, gastric cancer occupies the second leading cause of cancer-related deaths worldwide with an increasing trend.

18 Sep 2018

EKF Diagnostics to showcase new Stanbio GA assay kit at AACC 2018

EKF, announces it will highlight a new Stanbio Chemistry Glycated Albumin assay kit and its newly FDA cleared DiaSpect Tm hemoglobin point of care analyzer.

From EKF Diagnostics 31 Jul 2018

Okayama University research could improve prognosis of diabetic kidney disease

Researchers at Okayama University report in the journal Diabetes Care their findings on measurements of ion concentration in solutions for clinical and environmental research. The results are expected to improve prognosis of diabetic kidney disease.

17 Jul 2018

People with type 2 diabetes more likely to suffer from breathlessness, restrictive lung disease

Breathlessness and conditions of restrictive lung disease (RLD), such as pulmonary fibrosis, may be a late complication of type 2 diabetes.

11 Jul 2018

New algorithm predicts patients who will benefit from high blood pressure treatment

Using data from large clinical trials, UT Southwestern researchers developed a way to predict which patients will benefit most from aggressive high blood pressure treatment.

3 Jul 2018

Study shows benefits, safety of long-lasting radionuclide therapy for patients with advanced NETs

A first-in-human study presented at the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging demonstrates the benefits and safety of a new, long-lasting type of radionuclide therapy for patients with advanced, metastatic neuroendocrine tumors.

26 Jun 2018

BIDMC scientists develop new tool to benefit patients with HCV-associated liver failure

An estimated 3.5 million people in the United States have chronic hepatitis C (HCV), according to the Centers for Disease Control and Prevention.

18 Jun 2018

UVA researchers establish new guidelines for explorers of the submicroscopic world inside us

Researchers from the University of Virginia have established new guidelines for scientists mapping out the body molecule by molecule to help us better understand how our cells use metals such as iron and magnesium to maintain good health.

26 May 2018

Women with gestational diabetes may be at greater risk for chronic kidney disease

Gestational diabetes may predispose women to early-stage kidney damage, a precursor to chronic kidney disease, according to a study by researchers at the National Institutes of Health and other institutions. The study appears in Diabetes Care.

21 May 2018

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

Siemens Healthineers and Hill-Rom signed a co-marketing agreement to provide a suite of point-of-care diagnostic instruments that, for the first time, enable primary healthcare providers in the U.S. to bridge gaps in diabetes care and satisfy value-based quality measures in a single office visit.

From Siemens Healthineers Point of Care Diagnostics 16 May 2018

Analysis reveals decreasing trend in infection-related mortality among kidney transplant recipients

Since the 1990s, the risk of dying from infections after kidney transplantation has dropped by half, according to a recent analysis. The analysis, which appears in an upcoming issue of the Clinical Journal of the American Society of Nephrology, also found that common bacterial infections remain the most frequent cause of infection-related death among transplant recipients.

6 Apr 2018